Powder: -20°C for 3 years | In solvent: -80°C for 1 year
D-AP5 (D-APV) is a NMDA receptor antagonist.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 7,000 | |||
2 mg | 在庫あり | ¥ 9,500 | |||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 26,000 | |||
25 mg | 在庫あり | ¥ 55,000 | |||
50 mg | 在庫あり | ¥ 109,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 14,500 |
説明 | D-AP5 (D-APV) is a NMDA receptor antagonist. |
ターゲット&IC50 | NMDA:1.4 μM(kd) |
In vivo | D-AP5 is an NMDA receptor antagonist. Chronic intraventricular injection of D-AP5 can cause dose-dependent parallel damage to spatial learning and long-term enhancement (LTP) in vivo. When preventing spatial learning, the concentration of D-AP5 in the brain cannot cause any measurable sensorimotor disturbances. Compared with the test, D-AP5 infusion will cause a gradual decrease in swimming speed. D-AP5 causes sensorimotor disturbances in space tasks, but gradually deteriorates due to the inability of animals to learn. Rats treated with D-AP5 showed spatially dependent delay-dependent defects in the delayed matching placement protocol of the water maze. |
別名 | D-APV, D-2-Amino-5-phosphonovaleric acid |
分子量 | 197.13 |
分子式 | C5H12NO5P |
CAS No. | 79055-68-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble)
H2O: 27.78 mg/mL (140.92 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
D-AP5 79055-68-8 Membrane transporter/Ion channel Neuroscience NMDAR iGluR inhibit D-AP-5 Ionotropic glutamate receptors DAP5 D-APV Inhibitor D AP5 D-2-Amino-5-phosphonovaleric acid inhibitor